Bruker

This application note demonstrates how advanced LC-MS techniques provide comprehensive fusion protein characterization.

This application note explores how the combination of advanced ion mobility technology, fragmentation processes and sensitive detection enable the identification of low-abundance peptides, metabolites and lipids in complex biological samples.

Bruker's OptoVolt™ Module for Ultima 2Pplus multiphoton microscopes enables fast and flexible neural millisecond imaging for advanced voltage imaging applications.

This eBook explores how TIMS technology is driving innovations in lipidomics, enabling breakthroughs in disease research and therapeutic development.

This case study explores how TIMS is driving innovation in proteomics, enabling breakthroughs in biological research and clinical applications.

Jeffery Zonderman, senior vice-president at Bruker Applied MS, joined Technology Networks for an interview at this year's American Society for Mass Spectrometry event.

In this webinar, our expert speaker will discuss how HPLC-MS can detect a wide range of allergens in a single run, reducing the time and effort involved in food analysis.

Hear about the latest advancements in translational proteomics and metabolomics. From the molecular mechanisms of disease pathology to the latest technological developments in diagnostics and treatment.

MALDI mass spectrometry imaging has emerged as a powerful technology platform for spatially resolved analysis and visualization of a wide range of molecules – including drugs, metabolites, peptides and more – in pharmaceutical R&D, clinical research and basic science. Advances in MALDI workflows are making the technique more accessible.
In this webinar, our speaker will discuss how a new MALDI workflow can be used to analyze lipids in degenerative disease and Alzheimer’s models, contextualizing lipid distribution by enabling comparison to multiple protein markers.
He’ll also highlight how the new workflow can be applied to the study of tumor subtypes and the tumor microenvironment.

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based tissue imaging.